Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings; Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome; Decision further solidifies Vedanta's leading

Press/Media

Period7 May 2019

Media coverage

1

Media coverage

  • TitleVedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings; Upheld patent EP2575835 covers therapeutic compositions of clostridial bacterial species derived from the human microbiome; Decision further solidifies Vedanta's leading
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date7/05/19
    PersonsJeremiah Faith